Physician Payments

Effective 31st March 2013, GSK is required annually to submit data to the Centers for Medicare and Medicaid Services (CMS) Open Payment program as an applicable manufacturer. The Affordable Care Act requires CMS to collect information from applicable manufacturers and group purchasing organizations (GPOs) in order to report information about their financial relationships with physicians and hospitals. Open Payments is the federally run program that collects the information about these financial relationships and makes it available to the public annually on 30th June for payment data of prior calendar year.

The CMS open payments website allows you to view GSK's financial relationships with US Physicians and hospitals. Additionally, you will be able to view the relationships physicians and hospitals maintain with other companies.

To view GSK’s overall disclosure of payments to US Physicians related to speaking, advising, consulting, and other transfers of value:


      -     Search CMS Open Data Tool - https://openpaymentsdata.cms.gov/search
      -     Select tab “Company Making Payments”
      -     Input company name “GlaxoSmithKline” and hit search button
      -     Select “GlaxoSmithKline”
      -     You will be provided with a summary of GSK’s overall payment information and the ability to search and view payment
            information for individual physicians and teaching hospitals.

We are committed to transparency in our work, and committed to meeting all state and federal reporting requirements including the Open Payments Report (commonly known as The Sunshine Act) as well as a Corporate Integrity Agreement (CIA) in which GSK entered in July 2012 with the Office of the Inspector General for the Department of Health and Human Services (HHS). Disclosure requirements in the CIA and the Open Payments Report are aligned.

GSK is committed to providing as complete and accurate a disclosure report as possible and has established internal processes to continually review and validate our accuracy and disclosures. Questions about GSK disclosures should be submitted to the GSK Response Center at 1-888-725-0016. Hours are Monday through Friday from 8:30 AM to 5:30 PM Eastern Time